Geoffrey Hardman
University of York
22 Papers
218 Citations
Geoffrey Hardman is an academic researcher from University of York. The author has contributed to research in topics: Medicine & Health care. The author has an hindex of 11, co-authored 22 publications.
Chat about Author
Papers
•Posted Content
UK population norms for EQ-5D
TL;DR: This discussion paper presents data from the Department of Health funded Measurement and Valuation of Health survey conducted at the Centre for Health Economics in 1993, as a series of tables of age/sex population norms for the EuroQol (EQ-5D) descriptive system.
730
•Posted Content
A formula for distributing NHS revenues based on small area use of hospital beds
TL;DR: The primary purpose of the study was to “improve the sensitivity of the current formula for allocating Hospital and Community Health Service funds to Regional Health Authorities”.
156
Allocating resources to health authorities: results and policy implications of small area analysis of use of inpatient services.
TL;DR: The model for the psychiatric sector contains mortality, self reported morbidity, and social variables indicating deprivation and the level of care at home, and the non-acute model contains mortality and several socioeconomic variables.
Socioeconomic inequality in small area use of elective total hip replacement in the English National Health Service in 1991 and 2001.
TL;DR: Socioeconomic small area inequality in use of total hip replacement appears to have fallen between 1991 and 2001, suggesting that increased hip replacement rates in the 1990s may have lowered barriers to access, thus allowing this health technology to diffuse further among lower socio-economic groups.
38
Competition and Inequality: Evidence from the English National Health Service 1991–2001
TL;DR: This claim is tested in relation to the ‘‘internal market’’ reforms of the English National Health Service from 1991 to 97, which injected a small dose of hospital competition into a state-funded, state-owned health system responsible for more than 90% of national health expenditure.
36